These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26303765)

  • 21. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
    Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of adenosine as adjunctive therapy in acute myocardial infarction.
    Forman MB; Stone GW; Jackson EK
    Cardiovasc Drug Rev; 2006; 24(2):116-47. PubMed ID: 16961725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine reduces the threshold of remote ischemic preconditioning against myocardial ischemia and reperfusion injury in rats: the role of opioid receptors.
    Lu Y; Dong CS; Yu JM; Li H
    J Cardiothorac Vasc Anesth; 2012 Jun; 26(3):403-6. PubMed ID: 21982329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin and myocardial ischemia-reperfusion injury.
    Hu J; Lu Y
    Int J Cardiol; 2016 Nov; 222():988. PubMed ID: 27526377
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is it time to translate ischemic preconditioning's mechanism of cardioprotection into clinical practice?
    Cohen MV; Downey JM
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):273-80. PubMed ID: 21821528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin protects the heart against ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome.
    Yu SY; Tang L; Zhao GJ; Zhou SH
    Int J Cardiol; 2017 Feb; 229():23-24. PubMed ID: 27865664
    [No Abstract]   [Full Text] [Related]  

  • 31. Absence of actions of commonly used Chinese herbal medicines and electroacupuncture on myocardial infarct size.
    Dow J; Painovich J; Hale SL; Tjen-A-Looi S; Longhurst JC; Kloner RA
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):403-11. PubMed ID: 22549008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels.
    Liem DA; Gho CC; Gho BC; Kazim S; Manintveld OC; Verdouw PD; Duncker DJ
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1256-62. PubMed ID: 14993257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial protection at a crossroads: the need for translation into clinical therapy.
    Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
    Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
    D'Annunzio V; Donato M; Erni L; Miksztowicz V; Buchholz B; Carrión CL; Schreier L; Wikinski R; Gelpi RJ; Berg G; Basso N
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):137-44. PubMed ID: 19188835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotection and myocardial reperfusion: pitfalls to clinical application.
    Vander Heide RS; Steenbergen C
    Circ Res; 2013 Aug; 113(4):464-77. PubMed ID: 23908333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.
    Baker JE; Kozik D; Hsu AK; Fu X; Tweddell JS; Gross GJ
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):337-45. PubMed ID: 17577097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury.
    Hayashida K; Sano M; Ohsawa I; Shinmura K; Tamaki K; Kimura K; Endo J; Katayama T; Kawamura A; Kohsaka S; Makino S; Ohta S; Ogawa S; Fukuda K
    Biochem Biophys Res Commun; 2008 Aug; 373(1):30-5. PubMed ID: 18541148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic erythropoietin treatment limits infarct-size in the myocardium in vitro.
    Bullard AJ; Yellon DM
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):333-6. PubMed ID: 16382295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.